Maternal serum markers for Down's syndrome pregnancies

Area of Science:

• Prenatal diagnostics
• Medical genetics
• Biochemistry

Background:

• Down's syndrome is the most common chromosomal abnormality.
• Maternal age is a known risk factor, but most Down's syndrome cases occur in mothers under 35.
• Maternal serum markers are utilized for screening, particularly in lower-risk pregnancies.

Purpose of the Study:

• To review second-trimester maternal serum markers for Down's syndrome detection.
• To evaluate the effectiveness and limitations of the Triple test.
• To explore the cost-effectiveness and role of screening in different maternal age groups.

Main Methods:

• Review of existing literature on second-trimester maternal serum markers.
• Analysis of the Triple test, comprising alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol.
• Discussion of first-trimester serum markers and the need for further research.

Main Results:

• The Triple test is a widely used screening method for Down's syndrome.
• It achieves a 58% detection rate with a 5% false positive rate.
• Limitations of the Triple test are discussed, alongside its cost-effectiveness and application in various maternal age groups.

Conclusions:

• The Triple test is a common, though imperfect, tool for Down's syndrome screening.
• Further research is required to establish reliable first-trimester serum marker screening programs.
• Optimizing screening strategies for Down's syndrome remains an ongoing area of investigation.